Stock-Based Compensation (Tables)

3 Months Ended

Mar. 31, 2020

Share-based Payment Arrangement [Abstract]

Schedule of Share-based Compensation, Stock Options and Stock Appreciation Rights Award Activity

The following table presents certain information related to the activity of our non-vested stock option grants:

	Number of Stock Options	Weighted Average Exercise Prices		Weighted Average Remaining Contractual Term (years)	Aggregate Intrinsic Value
Outstanding as of December 31, 2019	207,069	$	18.69	9.00	$	—
Granted	—	—		—	—
Less: Forfeited	—	—		—	—
Less: Exercised	—	—		—	—
Outstanding as of March 31, 2020	207,069	$	18.69	8.75	$	—
Vested as of March 31, 2020	35,965	$	20.94	8.51	$	—
Exercisable as of March 31, 2020	35,965	$	20.94	8.51	$	—

Schedule of Nonvested Share Activity

The following table presents certain information related to the activity of our non-vested common stock grants:

	Number of Restricted Shares	Weighted Average Grant Date Fair Value
Outstanding as of December 31, 2019	214,495	$	17.49
Granted	1,175	8.75
Less: Forfeited	400	16.54
Less: Vested	25,753	16.67
Outstanding as of March 31, 2020	189,517	$	17.55

Share-based Payment Arrangement, Activity

The following table presents our total stock-based compensation expense:

	Three Months Ended March 31,
	2020		2019
Employee stock-based compensation expense
Pre-tax	$	526	$	530
Post-tax (1)	416		419
Director stock-based compensation expense
Pre-tax	174		371
Post-tax (1)	137		293

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The following weighted-average assumptions were used to value the stock options granted:

	2020
Expected annual dividend yield	1.28	%
Expected volatility	41.07	%
Risk-free interest rate	3.11	%
Expected term	6	years